Ligand Pharmaceuticals Incorporated Stock Price History
LGND Stock | USD 122.70 1.23 1.01% |
Below is the normalized historical share price chart for Ligand Pharmaceuticals Incorporated extending back to November 18, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ligand Pharmaceuticals stands at 122.70, as last reported on the 2nd of December, with the highest price reaching 124.00 and the lowest price hitting 119.18 during the day.
If you're considering investing in Ligand Stock, it is important to understand the factors that can impact its price. Ligand Pharmaceuticals appears to be very steady, given 3 months investment horizon. Ligand Pharmaceuticals has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Ligand Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Ligand Pharmaceuticals' Downside Deviation of 2.67, mean deviation of 1.87, and Risk Adjusted Performance of 0.0737 to check out if our risk estimates are consistent with your expectations.
The current year's Total Stockholder Equity is expected to grow to about 736 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 16.2 M. . The current year's Price Earnings Ratio is expected to grow to 24.87, whereas Price To Sales Ratio is forecasted to decline to 9.20. Ligand Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of November 1992 | 200 Day MA 92.3286 | 50 Day MA 109.707 | Beta 0.896 |
Ligand |
Sharpe Ratio = 0.1219
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | LGND | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.66 actual daily | 23 77% of assets are more volatile |
Expected Return
0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Ligand Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ligand Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.7286 | Enterprise Value Ebitda 21.7539 | Price Sales 15.1922 | Shares Float 18.5 M | Wall Street Target Price 140.25 |
Ligand Pharmaceuticals Stock Price History Chart
There are several ways to analyze Ligand Stock price data. The simplest method is using a basic Ligand candlestick price chart, which shows Ligand Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 7, 2024 | 129.9 |
Lowest Price | September 27, 2024 | 97.37 |
Ligand Pharmaceuticals December 2, 2024 Stock Price Synopsis
Various analyses of Ligand Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ligand Stock. It can be used to describe the percentage change in the price of Ligand Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ligand Stock.Ligand Pharmaceuticals Accumulation Distribution | 3,240 | |
Ligand Pharmaceuticals Price Rate Of Daily Change | 1.01 | |
Ligand Pharmaceuticals Price Daily Balance Of Power | 0.26 | |
Ligand Pharmaceuticals Price Action Indicator | 1.73 |
Ligand Pharmaceuticals December 2, 2024 Stock Price Analysis
Ligand Stock Price History Data
The price series of Ligand Pharmaceuticals for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 32.53 with a coefficient of variation of 7.06. The daily prices for the period are spread out with arithmetic mean of 108.25. The median price for the last 90 days is 105.86. The company underwent 1603:1000 stock split on 2nd of November 2022. Ligand Pharmaceuticals issued dividends to stockholders on 2010-07-02.Open | High | Low | Close | Volume | ||
12/02/2024 | 120.58 | 124.00 | 119.18 | 122.70 | 83,356 | |
11/29/2024 | 123.44 | 124.34 | 120.01 | 121.47 | 57,263 | |
11/27/2024 | 123.65 | 124.59 | 121.06 | 122.55 | 88,894 | |
11/26/2024 | 120.62 | 124.44 | 119.78 | 124.33 | 182,785 | |
11/25/2024 | 119.74 | 122.63 | 119.19 | 120.62 | 153,640 | |
11/22/2024 | 116.22 | 120.00 | 116.22 | 119.19 | 90,758 | |
11/21/2024 | 112.06 | 118.12 | 112.06 | 116.55 | 83,313 | |
11/20/2024 | 111.59 | 112.00 | 109.71 | 111.56 | 133,450 | |
11/19/2024 | 110.72 | 112.27 | 109.78 | 111.80 | 98,164 | |
11/18/2024 | 110.87 | 112.90 | 109.44 | 111.67 | 123,658 | |
11/15/2024 | 116.52 | 116.52 | 110.32 | 111.71 | 104,104 | |
11/14/2024 | 123.22 | 125.76 | 114.39 | 115.45 | 129,171 | |
11/13/2024 | 122.00 | 123.72 | 121.35 | 122.08 | 219,056 | |
11/12/2024 | 123.08 | 124.46 | 119.69 | 120.74 | 120,531 | |
11/11/2024 | 122.24 | 124.19 | 120.83 | 123.47 | 209,237 | |
11/08/2024 | 126.27 | 127.26 | 116.96 | 121.25 | 260,600 | |
11/07/2024 | 118.33 | 129.90 | 115.16 | 129.90 | 271,689 | |
11/06/2024 | 114.09 | 116.95 | 111.81 | 116.90 | 214,603 | |
11/05/2024 | 109.57 | 111.59 | 108.31 | 111.13 | 82,981 | |
11/04/2024 | 109.14 | 110.63 | 108.11 | 110.22 | 98,327 | |
11/01/2024 | 107.05 | 110.79 | 107.05 | 110.04 | 121,354 | |
10/31/2024 | 109.00 | 109.56 | 105.48 | 105.70 | 92,515 | |
10/30/2024 | 114.93 | 115.10 | 109.81 | 109.81 | 63,892 | |
10/29/2024 | 112.98 | 115.53 | 112.98 | 115.53 | 118,689 | |
10/28/2024 | 113.26 | 113.51 | 110.00 | 113.38 | 206,900 | |
10/25/2024 | 111.19 | 113.37 | 111.13 | 111.82 | 122,059 | |
10/24/2024 | 106.89 | 111.04 | 106.32 | 110.99 | 143,895 | |
10/23/2024 | 106.29 | 107.28 | 104.58 | 106.89 | 64,218 | |
10/22/2024 | 106.19 | 106.51 | 104.29 | 106.50 | 65,158 | |
10/21/2024 | 106.83 | 109.41 | 106.55 | 106.78 | 120,535 | |
10/18/2024 | 106.08 | 106.54 | 104.25 | 106.39 | 53,604 | |
10/17/2024 | 107.50 | 107.99 | 105.17 | 105.89 | 71,901 | |
10/16/2024 | 104.50 | 107.76 | 104.35 | 107.16 | 109,931 | |
10/15/2024 | 103.06 | 105.67 | 102.99 | 104.39 | 64,094 | |
10/14/2024 | 103.06 | 103.59 | 101.99 | 103.46 | 60,338 | |
10/11/2024 | 100.73 | 103.03 | 100.23 | 102.94 | 79,775 | |
10/10/2024 | 102.05 | 102.13 | 98.90 | 100.32 | 76,574 | |
10/09/2024 | 101.77 | 104.48 | 101.77 | 103.24 | 72,115 | |
10/08/2024 | 102.95 | 105.50 | 102.30 | 102.97 | 57,545 | |
10/07/2024 | 104.78 | 104.78 | 102.16 | 102.62 | 73,235 | |
10/04/2024 | 103.64 | 105.74 | 102.20 | 104.78 | 69,002 | |
10/03/2024 | 101.04 | 105.89 | 100.00 | 102.24 | 84,576 | |
10/02/2024 | 101.08 | 101.08 | 99.71 | 99.95 | 51,976 | |
10/01/2024 | 100.10 | 102.15 | 97.86 | 101.35 | 99,456 | |
09/30/2024 | 98.16 | 100.33 | 97.85 | 100.09 | 73,379 | |
09/27/2024 | 100.38 | 100.69 | 96.96 | 97.37 | 83,300 | |
09/26/2024 | 99.73 | 101.01 | 98.40 | 99.38 | 88,439 | |
09/25/2024 | 99.16 | 99.48 | 98.06 | 98.78 | 68,909 | |
09/24/2024 | 99.86 | 100.39 | 97.48 | 99.54 | 63,600 | |
09/23/2024 | 103.29 | 103.29 | 99.27 | 99.66 | 101,566 | |
09/20/2024 | 104.41 | 105.23 | 102.80 | 102.80 | 334,864 | |
09/19/2024 | 105.41 | 106.20 | 104.35 | 105.01 | 84,755 | |
09/18/2024 | 103.62 | 105.91 | 103.18 | 103.68 | 81,566 | |
09/17/2024 | 105.50 | 106.32 | 104.01 | 104.26 | 91,561 | |
09/16/2024 | 104.77 | 106.65 | 104.41 | 105.00 | 93,403 | |
09/13/2024 | 102.62 | 105.40 | 102.62 | 104.77 | 89,879 | |
09/12/2024 | 103.16 | 104.11 | 101.98 | 102.10 | 54,300 | |
09/11/2024 | 101.01 | 103.54 | 101.01 | 103.09 | 66,246 | |
09/10/2024 | 103.10 | 104.28 | 101.73 | 102.23 | 62,746 | |
09/09/2024 | 101.54 | 103.69 | 101.42 | 102.78 | 76,840 | |
09/06/2024 | 103.83 | 104.89 | 99.08 | 101.14 | 64,658 |
About Ligand Pharmaceuticals Stock history
Ligand Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ligand is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ligand Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ligand Pharmaceuticals stock prices may prove useful in developing a viable investing in Ligand Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 17.8 M | 16.2 M | |
Net Loss | -38.4 M | -36.4 M |
Ligand Pharmaceuticals Quarterly Net Working Capital |
|
Ligand Pharmaceuticals Stock Technical Analysis
Ligand Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Ligand Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ligand Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Ligand Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ligand to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0737 | |||
Jensen Alpha | 0.0366 | |||
Total Risk Alpha | (0.22) | |||
Sortino Ratio | 0.0362 | |||
Treynor Ratio | 0.1525 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Ligand Stock analysis
When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |